Compare ARK Genomic Revolution ETF (ARKG) vs Logitech International SA (LOGI) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Logitech International SA — how do they compare? ARK Genomic Revolution ETF trades at $41.25, while Logitech International SA trades at $101.5 (market cap $14.65B). The key difference: Logitech International SA pays a 1.67% dividend while ARK Genomic Revolution ETF pays none, and ARK Genomic Revolution ETF is trading nearer its 52-week high, Logitech International SA nearer its low. Which is the better fit depends on your goals.
| ARKG | LOGI | |
|---|---|---|
Sector | Sector/Thematic | Technology |
52-Week High | $43.57 | $126.69 |
52-Week Low | $23.09 | $85.84 |
Market Cap | — | $14.65B |
Enterprise Value | — | $13.00B |
Dividend Yield | — | 1.67% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
Logitech (LOGI) trades at $101.95, up 0.28% on the day, with a bullish technical signal despite mixed moving averages. The company reported strong earnings beats in recent quarters, with Q1 2026 EPS of $1.13 exceeding the $1.10 estimate. Fundamentals show robust profitability, including a 43.2% gross margin and 32.78% ROE, while valuation ratios like P/E of 21.25 and P/S of 3.12 reflect moderate pricing. Recent news highlights partnerships, such as with Call of Duty: Modern Warfare 4, and product launches like the G3 Series, supporting growth momentum.
The outlook for LOGI is cautiously optimistic, with a consensus price target of $113.00 implying 11% upside. Opportunities include B2B expansion and AI-enabled products driving margin growth, but risks involve competitive pressures in peripherals and reliance on consumer spending. Analyst sentiment is divided, with 26% buy ratings balanced by equal sell recommendations, indicating uncertainty amid solid execution.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Logitech International SA
Logitech International SA is a Switzerland-based provider of personal computer and mobile accessories for navigation, video communication, and collaboration, smart home, and other applications. Its product portfolio includes mice, keyboards, charging stands, tablet cases, car mounts for mobile devices, remotes, home cameras, home switches, controllers, bluetooth speakers, surround sound, webcams, and conference cameras. It operates in a single segment namely, Peripherals. The firm generates revenue from the Americas, EMEA (Europe, Middle East, Africa), and the Asia Pacific region.
Read more on LOGI →
